Overview
Robert Donegan is a Hematologist practicing medicine in Towson, Maryland.
Dr. Donegan is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Multiple Myeloma, and Gastric Lymphoma.
He is actively involved in clinical research, participating in 7 clinical trials. Dr. Donegan is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6569 N Charles St Ste 201, Towson, MD 21204
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.
Johns Hopkins Hospital
Michael Streiff is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Streiff is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration. Dr. Streiff is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Patrick Forde is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Forde is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and Small Cell Lung Cancer (SCLC). Dr. Forde is currently accepting new patients.
Frequently Asked Questions about Dr. Robert B. Donegan
How do I make an appointment with Dr. Robert B. Donegan?
You can book an appointment with Dr. Robert B. Donegan by calling their office at 443-849-3051. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Robert B. Donegan a top-rated expert for Non-Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert B. Donegan is classified as an Distinguished expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Robert B. Donegan specialize in?
While Dr. Robert B. Donegan is a Hematology, they have specific expertise in Non-Hodgkin Lymphoma, Follicular Lymphoma, and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Robert B. Donegan accept my insurance?
Dr. Robert B. Donegan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 443-849-3051 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Non-Hodgkin LymphomaDr. Donegan isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Advanced
- Chronic B-Cell Leukemia (CBCL)Dr. Donegan isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Donegan isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Follicular LymphomaDr. Donegan isAdvanced. Learn about Follicular Lymphoma.
- Gastric LymphomaDr. Donegan isAdvanced. Learn about Gastric Lymphoma.
- Multiple MyelomaDr. Donegan isAdvanced. Learn about Multiple Myeloma.
- Richter SyndromeDr. Donegan isAdvanced. Learn about Richter Syndrome.
- Waldenstrom MacroglobulinemiaDr. Donegan isAdvanced. Learn about Waldenstrom Macroglobulinemia.
- Experienced
- Adult Immune ThrombocytopeniaDr. Donegan isExperienced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung CancerDr. Donegan isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Donegan isExperienced. Learn about Anemia.
- Autoimmune Hemolytic AnemiaDr. Donegan isExperienced. Learn about Autoimmune Hemolytic Anemia.
- B-Cell LymphomaDr. Donegan isExperienced. Learn about B-Cell Lymphoma.
- Childhood Acute Myeloid LeukemiaDr. Donegan isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)Dr. Donegan isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Deep Vein ThrombosisDr. Donegan isExperienced. Learn about Deep Vein Thrombosis.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Donegan isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Essential ThrombocythemiaDr. Donegan isExperienced. Learn about Essential Thrombocythemia.
- Gallbladder AdenocarcinomaDr. Donegan isExperienced. Learn about Gallbladder Adenocarcinoma.
- Hemangioma Thrombocytopenia SyndromeDr. Donegan isExperienced. Learn about Hemangioma Thrombocytopenia Syndrome.
- Immune Thrombocytopenic Purpura (ITP)Dr. Donegan isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- Large-Cell Immunoblastic LymphomaDr. Donegan isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- LeukocytosisDr. Donegan isExperienced. Learn about Leukocytosis.
- Mantle Cell Lymphoma (MCL)Dr. Donegan isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Marginal Zone Lymphoma (MZL)Dr. Donegan isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Myelodysplastic Syndrome (MDS)Dr. Donegan isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisDr. Donegan isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Dr. Donegan isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Philadelphia-Negative Chronic Myeloid Leukemia
- Polycythemia VeraDr. Donegan isExperienced. Learn about Polycythemia Vera.
- Primary Lymphoma of the BrainDr. Donegan isExperienced. Learn about Primary Lymphoma of the Brain.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Schnitzler SyndromeDr. Donegan isExperienced. Learn about Schnitzler Syndrome.
- Sideroblastic AnemiaDr. Donegan isExperienced. Learn about Sideroblastic Anemia.
- Small Lymphocytic Lymphoma (SLL)Dr. Donegan isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- Smoldering Multiple MyelomaDr. Donegan isExperienced. Learn about Smoldering Multiple Myeloma.
- ThrombocytopeniaDr. Donegan isExperienced. Learn about Thrombocytopenia.
